0001209191-17-024889.txt : 20170404
0001209191-17-024889.hdr.sgml : 20170404
20170404164338
ACCESSION NUMBER: 0001209191-17-024889
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170331
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Onaitis Matthew
CENTRAL INDEX KEY: 0001362822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 17738982
MAIL ADDRESS:
STREET 1: C/O SOMAXON PHARMACEUTICALS, INC.
STREET 2: 10935 VISTA SORRENTO PARKWAY, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-31
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001362822
Onaitis Matthew
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO
CA
92121
0
1
0
0
Gnrl Counsel, CFO & Secretary
Employee Stock Option (right to buy)
7.80
2017-03-31
4
A
0
55000
0.00
A
2027-03-30
Common Stock
55000
55000
D
The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2017.
/s/ Marc Wilson, Attorney-in-fact
2017-04-04